about
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 productionHuman IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow.Insulin and glucose play a role in foam cell formation and function.Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form.Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAMEThe CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) inhibits high glucose-induced inflammation in vitro and in vivo.Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells.The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people.Baicalin, baicalein and wogonin inhibits high glucose-induced vascular inflammation in vitro and in vivo.An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease.Dibutyryl-cAMP affecting fat deposition of finishing pigs by decreasing the inflammatory system related to insulin sensitive or lipolysis.The enigmatic cytokine oncostatin m and roles in diseaseTime Series miRNA-mRNA integrated analysis reveals critical miRNAs and targets in macrophage polarizationAngiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.Computational modelling of atherosclerosis.NHE-1 and β1 integrin dependent monocyte adhesion and migration after glucose, insulin or PPARγ stimulation.Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo.Towards the Identification of Hemodynamic Parameters Involved in Arteriovenous Fistula Maturation and Failure: A Review.Lysophosphatidic acid effects on atherosclerosis and thrombosis.Vicenin-2 and scolymoside inhibit high-glucose-induced vascular inflammation in vitro and in vivo.Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).COUP-TFII switches responses of venous endothelium to atherosclerotic factors through controlling the profile of various inherent genes expression.Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice.Emodin-6-O-β-D--glucoside inhibits high-glucose-induced vascular inflammation.Association of CXCL1 promoter polymorphism with ischaemic stroke in Korean population.Nonviral monocyte chemoattractant protein-1 gene transfer improves arteriogenesis after femoral artery occlusion.Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.Orientin inhibits high glucose-induced vascular inflammation in vitro and in vivo.Hyperoside inhibits high-glucose-induced vascular inflammation in vitro and in vivo.Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects.The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development.Frequency-dependent response of the vascular endothelium to pulsatile shear stress.The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation.Interleukin-8 is associated with increased total mortality in women but not in men—findings from a community-based cohort of elderlyFermented bitter gourd extract differentially regulates lipopolysaccharide-induced cytokine gene expression through nuclear factor-κB and interferon regulatory factor-1
P2860
Q28580308-2E6AA358-32B1-49F9-87CA-5C2F547658CCQ30438030-B5CCB832-A27E-4D4F-B514-94E5AF686CA3Q30440798-CF3E16AC-5F1D-49A0-B657-BBFCD723117FQ33316838-FC542562-9897-45BD-ADD1-DA2F3153BCBAQ33816476-8ED0D640-5B55-4E3D-AE92-09FE0CCBA38BQ34074217-8F6A1582-E2D6-42DE-90E9-94872CE9E83CQ34157008-73D456BC-92F2-4ACE-8499-8AFF0746A80FQ34444546-C6EEB288-BFF7-4F38-83F1-5A9C45F4220FQ34553611-70C6E9B6-9940-44A6-9DD8-D2CEACD6B859Q35951580-50CDC3D6-099C-4FF3-AA7C-638BE330C002Q36269996-564D0ED2-20F4-49E7-A529-73D835C9D58DQ37019592-D6A2C78C-CFF5-4A09-8CBB-84676F21C9FAQ37142048-9D446C64-4EE1-4AB6-B227-F43F2553F7D6Q37409222-F6A43BCC-0BB0-4B9D-AAF7-18FFE087046DQ37508288-DC057FD8-2E25-4140-A245-9F4451FC6D99Q38315778-890968D5-40F1-4673-BE9A-BE5CC298AB1DQ38355976-B6D1FE1E-4175-43C0-B040-91B7F469155CQ38599711-3BC1ECAF-4E45-4920-BA2E-1227098FB7F0Q38974601-392AE56F-B9C9-4DC7-9076-CCAA1C1B3016Q38985463-7AEDF644-94A6-4CB5-9A10-D10007412714Q39458818-E18FA6E8-93F5-43C5-B528-25CF798B92F9Q39608397-8F906F3B-2346-464A-8C0B-FE54C03F1F64Q40108845-E08E6EF6-5855-4651-B216-BC1F8D84E4FDQ42285956-B8B98C59-FD7D-4B78-A3AF-0B68D4F888A7Q42479752-136385E2-9FF1-43DE-A5E7-0B0D3E8CFBCBQ42789241-99061CE4-DF63-4283-B036-403473D0160FQ43513292-076FC3AB-48B6-44C7-BBAB-59D088919927Q44816669-B58F4ED9-1424-45EF-9B33-12288564D6EAQ45878640-BC2FB360-4AC0-449B-B288-F96B6A6C006BQ46463936-81F1FD8D-4D10-4BFE-A3D9-B7BC5CC98C2BQ46876496-6989E959-4C1C-4BB8-80C9-F19FF42E9E65Q46922002-1F77EFBA-5625-455B-9354-99DED2352E50Q46954618-14141B2E-6E55-4B7A-89C3-2219F29AA42FQ50994462-62EDCB08-C283-4F3D-8440-E0AAFE3C0A21Q51061373-F65FF823-5DC5-4D0C-9E3F-F4656BD6C4BEQ52896348-AC7C2553-092E-49C6-85E5-E6272450358FQ57393819-BB02A06F-4A30-4F64-93ED-C70681274BEFQ58134111-1AC4CD4C-537D-465F-8FC2-195D95E84FFC
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Modulation of atherogenesis by chemokines.
@ast
Modulation of atherogenesis by chemokines.
@en
type
label
Modulation of atherogenesis by chemokines.
@ast
Modulation of atherogenesis by chemokines.
@en
prefLabel
Modulation of atherogenesis by chemokines.
@ast
Modulation of atherogenesis by chemokines.
@en
P1476
Modulation of atherogenesis by chemokines.
@en
P2093
William A Boisvert
P304
P356
10.1016/J.TCM.2004.02.006
P577
2004-05-01T00:00:00Z